| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr VP, Clinical Dev. & CMO | Sr VP Clinical Dev & CMO | Sr VP, Clinical Dev & CMO +1 more
1 company
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2018-01-17 | MGNX | Sr VP, Clinical Dev. & CMO | Sale+OE | 5,000 | $20.00 | $100,000.00 | -7.7% | → |
| 2017-11-21 | MGNX | Sr VP, Clinical Dev. & CMO | Sale+OE | 5,000 | $20.00 | $100,000.00 | -14.3% | → |
| 2017-10-25 | MGNX | Sr VP, Clinical Dev. & CMO | Sale+OE | 10,000 | $20.00 | $200,000.00 | -25.0% | → |
| 2017-06-05 | MGNX | Sr VP, Clinical Dev. & CMO | Sale+OE | 5,000 | $20.00 | $100,000.00 | -14.3% | → |
| 2017-04-19 | MGNX | Sr VP, Clinical Dev. & CMO | Sale+OE | 15,000 | $20.00 | $300,000.00 | -33.3% | → |
| 2016-10-03 | MGNX | Sr VP, Clinical Dev. & CMO | Sale+OE | 10,000 | $29.34 | $293,400.00 | -100% | → |
| 2016-08-01 | MGNX | Sr VP Clinical Dev & CMO | Sale+OE | 20,000 | $30.78 | $615,600.00 | -100% | → |
| 2016-07-01 | MGNX | Sr VP Clinical Dev & CMO | Sale+OE | 5,000 | $27.22 | $136,100.00 | -100% | → |
| 2016-01-04 | MGNX | Sr VP, Clinical | Sale+OE | 10,000 | $29.64 | $296,400.00 | -100% | → |
| 2015-10-01 | MGNX | Sr VP, Clinical | Sale+OE | 5,000 | $21.11 | $105,550.00 | -100% | → |
| 2015-08-03 | MGNX | Sr VP, Clinical | Sale+OE | 10,000 | $37.15 | $371,500.00 | -100% | → |
| 2015-07-01 | MGNX | Sr VP, Clinical | Sale+OE | 5,000 | $37.15 | $185,750.00 | -100% | → |
| 2015-04-01 | MGNX | Sr VP, Clinical | Sale+OE | 5,000 | $30.86 | $154,300.00 | -100% | → |
| 2015-02-02 | MGNX | Sr VP, Clinical | Sale+OE | 5,000 | $31.04 | $155,200.00 | -100% | → |